Management Of Acute PE Flashcards
Learn the NICE diagram for management of acute PE
Go to notes
Describe how you would risk stratify PE patients
- are they haemodynamically stable? (Yes = high risk)
- if PESI class III-IV (86-125 points) troponin positive + RV dysfunction = intermediate high risk
- if PESI class III-IV with/without RV dysfunction but troponin negative = intermediate low risk
- neither of these symptoms/signs = low risk
When would you commence anticoagulation treatment in patients with PE?
As soon as you clinically suspect that the patient is having a PE (unless contraindicated)
What defines haemodynamic instability?
- systolic BP less than 90mmHg
- drop of >40mmHg for more than 15 mins in absence of other cause
- cardiac arrest
Describe how to assess cardiac risk of patients
Echo/CT parameters:
- RV dilation
- RV strain
- increased TRPG (tricuspid regurgitation pressure gradient)
- hypokinesis RV wall
Biomarkers:
- troponin
- BNP
- NT-proBNP
Describe the parameters in the PESI score
- age
- male sex (10)
- cancer (30)
- chronic HF (10)
- chronic pulmonary disease (10)
- pulse rate >110bpm (20)
- systolic BP <100 mmHg (30)
- resp rate >30 (20)
- temp <36 degrees (20)
- altered mental status (60)
- sats <90% (20)
How would you manage a patient with suspected PE with haemodynamic instability?
- bedside echo to confirm RV dysfunction
- if positive take for CT pulmonary angiography
- if positive then high risk and commence treatment to manage the right heart
- volume optimisation (if low venous pressure) = saline bolus
- vasopressors + ionotropes = norepinephrine, dobutamine
- mechanical circulatory support = ECMO
What is the reperfusion therapy options for PE patients?
- systemic thrombolysis
- catheter directed thrombolysis
- surgical approach
When is thrombolysis indicated?
- high risk PE
- patients with severe RV dysfunction due to PE
- presence of severe hypoxemia (esp with concurrent CV illness)
- decompensation but not yet hypotensive
- extensive clot burden
List the effects of thrombolysis
- improvement of pulmonary vascular resistance
- improved RV function
- improved pulmonary pressure + perfusion
What agents are used in thrombolysis?
- alteplase
- streptokinase
- urokinase
Why do we not give thrombolysis treatment to intermediate or low risk PE patients?
it may improve RV function but it can increase the risk substantially of an intra-cranial bleed
What are the benefits and disadvantages of catheter directed thrombolysis?
Benefits:
- safer in terms of bleeds
- lower doses used
- consider when bleeding risk is high
- can allow direct clot retrieval
Disadvantages:
- not readily available
- takes time to set up